Neurotech Phase II/III Autism Trial Successfully Meets Primary Endpoint Highlights:
• NTIASD2 Phase II/III clinical trial met the primary endpoint of a statistically significant improvement in severity of illness (CGI-S) at 8 weeks between NTI164 and placebo (p<0.001)
• Children in NTI164 group re-classified from markedly-severely ill (CGI-S: 5.54) at baseline to mild-moderately ill (CGI-S: 3.77) at 8 weeks, a very strong improvement
• Key Secondary endpoints examining adaptive behaviour improvements (Vineland™-3) (p=0.024), CGI-Improvement (p<0.001) social responsiveness (p=0.028), were met with strong treatment-related benefits over placebo
• No serious adverse events recorded, no changes to kidney/liver function over the 8-week period noted, no treatment-related diarrhoea and nausea/vomiting rate lower for NTI164 arm
• Neurotech to accelerate registration-related regulatory discussions given strength of data
• NDIS spend of $6.73 billion to participants with Autism highlights dire need for a safe and effective therapeutic intervention to improve ASD symptoms and reduce healthcare costs
https://www.investi.com.au/api/announcements/nti/3e87a498-65a.pdf
- Forums
- ASX - By Stock
- NTI
- Ann: Phase II/III ASD Trial Successfully Meets Primary Endpoint
Ann: Phase II/III ASD Trial Successfully Meets Primary Endpoint, page-2
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NTI (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.9¢ |
Change
-0.001(1.43%) |
Mkt cap ! $70.21M |
Open | High | Low | Value | Volume |
7.0¢ | 7.1¢ | 6.8¢ | $87.67K | 1.254M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 266170 | 6.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.9¢ | 26410 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 266170 | 0.068 |
2 | 255000 | 0.067 |
4 | 272000 | 0.066 |
4 | 182930 | 0.065 |
4 | 826890 | 0.064 |
Price($) | Vol. | No. |
---|---|---|
0.069 | 26410 | 1 |
0.071 | 338990 | 2 |
0.072 | 77591 | 1 |
0.074 | 40000 | 1 |
0.075 | 1039683 | 3 |
Last trade - 15.58pm 17/09/2024 (20 minute delay) ? |
Featured News
NTI (ASX) Chart |